Structural abnormalities resulting in chimeric gene fusion between MECOM locus at 3q26.2 and various partner genomic loci, with either known or unknown gene content in hematologic neoplasms, as documented in the public databases and literature. This evidence concerns the gene MECOM and hematopoietic and lymphoid system neoplasm.